MSK Announces Closing of Financing for NASDAQ Client VBIV
September 4, 2014
Mitchell, Silberberg & Knupp* announced that its client VBI Vaccines Inc. (NASDAQ: VBIV) entered into and completed the initial drawdown of a $6 million credit facility from Perceptive Advisors.
The Mitchell, Silberberg & Knupp* team was led by Co-Managing Partner, Kevin Friedmann, and included Gabrielle Napolitano and Bryan Wasser. VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets.
*Handled through the predecessor law firm of Richardson Patel LLP.